High oxygen tension prolongs the survival of osteoclast precursors via macrophage colony-stimulating factor

Bone

Volumn 44, Issue 1, 2009, Pages 71-79

  Yamasaki, Naomi ^a   Tsuboi, Hideki ^a   Hirao, Makoto ^a   Nampei, Akihide ^a   Yoshikawa, Hideki ^a   Hashimoto, Jun ^a  

^a OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Destructive bone lesions; Hyperoxia; Macrophage colony stimulating factor; Osteoclast precursor; Prolonged survival

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; COLONY STIMULATING FACTOR 1; COMPLEMENTARY DNA; NEUTRALIZING ANTIBODY; OXYGEN; REACTIVE OXYGEN METABOLITE; RECOMBINANT COLONY STIMULATING FACTOR 1; RNA;

ANGIOGENESIS; ANIMAL TISSUE; ARTICLE; BLOOD VESSEL; BONE DISEASE; CELL SURVIVAL; CLINICAL ARTICLE; HISTOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPEROXIA; IMMUNOHISTOCHEMISTRY; KNEE OSTEOARTHRITIS; MOUSE; NONHUMAN; OSTEOCLAST; OXIDATIVE STRESS; OXYGEN TENSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RHEUMATOID ARTHRITIS; TOTAL KNEE REPLACEMENT; WESTERN BLOTTING;

ACID PHOSPHATASE; ANTIBODIES; ANTIGENS, CD14; BONE AND BONES; CELL LINE; CELL SURVIVAL; GENE EXPRESSION REGULATION; HUMANS; ISOENZYMES; MACROPHAGE COLONY-STIMULATING FACTOR; MONOCYTES; NEOVASCULARIZATION, PATHOLOGIC; NEUTRALIZATION TESTS; OSTEOCLASTS; OXYGEN; REACTIVE OXYGEN SPECIES; RECEPTOR, MACROPHAGE COLONY-STIMULATING FACTOR; STEM CELLS;

EID: 57449102544     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2008.09.015     Document Type: Article

References (54)

1. Bathurst N., Sanerkin N., and Watt I. Osteoclast-rich osteosarcoma. Br. J. Radiol. 59 (1986) 667-673
2. Romas E., Gillespie M.T., and Martin T.J. Involvement of receptor activator of NFkappaB ligand and tumor necrosis factor-alpha in bone destruction in rheumatoid arthritis. Bone 30 (2002) 340-346
3. Yamakawa T., Sudo A., Tanaka M., and Uchida A. Microvascular density of rapidly destructive arthropathy of the hip joint. J. Orthop. Surg. (Hong. Kong) 13 (2005) 40-45
4. Kindle L., Rothe L., Kriss M., Osdoby P., and Collin-Osdoby P. Human microvascular endothelial cell activation by IL-1 and TNF-alpha stimulates the adhesion and transendothelial migration of circulating human CD14+ monocytes that develop with RANKL into functional osteoclasts. J. Bone Miner. Res. 21 (2006) 193-206
5. Malemud C.J. Growth hormone, VEGF and FGF: involvement in rheumatoid arthritis. Clin. Chim. Acta 375 (2007) 10-19
6. Koizumi F., Matsuno H., Wakaki K., Ishii Y., Kurashige Y., and Nakamura H. Synovitis in rheumatoid arthritis: scoring of characteristic histopathological features. Pathol. Int. 49 (1999) 298-304
7. Rooney M., Condell D., Quinlan W., Daly L., Whelan A., Feighery C., et al. Analysis of the histologic variation of synovitis in rheumatoid arthritis. Arthritis Rheum. 31 (1988) 956-963
8. Matsuno H., Yudoh K., Nakazawa F., and Koizumi F. Relationship between histological findings and clinical findings in rheumatoid arthritis. Pathol. Int. 52 (2002) 527-533
9. Hoang B.H., Dyke J.P., Koutcher J.A., Huvos A.G., Mizobuchi H., Mazza B.A., et al. VEGF expression in osteosarcoma correlates with vascular permeability by dynamic MRI. Clin. Orthop. Relat. Res. 426 (2004) 32-38
10. Kajihara M., Sugawara Y., Sakayama K., Kikuchi K., Mochizuki T., and Murase K. Evaluation of tumor blood flow in musculoskeletal lesions: dynamic contrast-enhanced MR imaging and its possibility when monitoring the response to preoperative chemotherapy-work in progress. Radiat. Med. 25 (2007) 94-105
11. Winding B., Misander H., Sveigaard C., Therkildsen B., Jakobsen M., Overgaard T., et al. Human breast cancer cells induced angiogenesis, recruitment, and activation of osteoclasts in osteolytic metastasis. J. Cancer Res. Clin. Oncol. 126 (2000) 631-640
12. Hirao M., Hashimoto J., Yamasaki N., Ando W., Tsuboi H., Myoui A., et al. Oxygen tension is an important mediator of the transformation of osteoblasts to osteocytes. J. Bone Miner. Metab. 25 (2007) 266-276
13. Hirao M., Tamai N., Tsumaki N., Yoshikawa H., and Myoui A. Oxygen tension regulates chondrocyte differentiation and function during endochondral ossification. J. Biol. Chem. 281 (2006) 31079-31092
14. Fukuoka H., Aoyama M., Miyazawa K., Asai K., and Goto S. Hypoxic stress enhances osteoclast differentiation via increasing IGF2 production by non-osteoclastic cells. Biochem. Biophys. Res. Commun. 328 (2005) 885-894
15. Arnett T.R., Gibbons D.C., Utting J.C., Orriss I.R., Hoebertz A., Rosendaal M., et al. Hypoxia is a major stimulator of osteoclast formation and bone resorption. J. Cell Physiol. 196 (2003) 2-8
16. Tsuboi H., Udagawa N., Hashimoto J., Yoshikawa H., Takahashi N., and Ochi T. Nurse-like cells from patients with rheumatoid arthritis support the survival of osteoclast precursors via macrophage colony-stimulating factor production. Arthritis Rheum. 52 (2005) 3819-3828
17. Matsuzaki K., Katayama K., Takahashi Y., Nakamura I., Udagawa N., Tsurukai T., et al. Human osteoclast-like cells are formed from peripheral blood mononuclear cells in a coculture with SaOS-2 cells transfected with the parathyroid hormone (PTH)/PTH-related protein receptor gene. Endocrinology 140 (1999) 925-932
18. Itoh K., Udagawa N., Matsuzaki K., Takami M., Amano H., Shinki T., et al. Importance of membrane- or matrix-associated forms of M-CSF and RANKL/ODF in osteoclastogenesis supported by SaOS-4/3 cells expressing recombinant PTH/PTHrP receptors. J. Bone Miner. Res. 15 (2000) 1766-1775
19. Arnett F.C., Edworthy S.M., Bloch D.A., McShane D.J., Fries J.F., Cooper N.S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum. 31 (1988) 315-324
20. Flanagan A.M., and Massey H.M. Generating human osteoclasts in vitro from bone marrow and peripheral blood. Methods Mol. Med. 80 (2003) 113-128
21. Matsuzaki K., Udagawa N., Takahashi N., Yamaguchi K., Yasuda H., Shima N., et al. Osteoclast differentiation factor (ODF) induces osteoclast-like cell formation in human peripheral blood mononuclear cell cultures. Biochem. Biophys. Res. Commun. 246 (1998) 199-204
22. Kirstein B., Grabowska U., Samuelsson B., Shiroo M., Chambers T.J., and Fuller K. A novel assay for analysis of the regulation of the function of human osteoclasts. J. Transl. Med. 4 (2006) 45
23. von Zglinicki T., Saretzki G., Docke W., and Lotze C. Mild hyperoxia shortens telomeres and inhibits proliferation of fibroblasts: a model for senescence?. Exp. Cell Res. 220 (1995) 186-193
24. Teitelbaum S.L. Osteoclasts: what do they do and how do they do it?. Am. J. Pathol. 170 (2007) 427-435
25. Vignery A. Macrophage fusion: the making of osteoclasts and giant cells. J. Exp. Med. 202 (2005) 337-340
26. Kukita T., Wada N., Kukita A., Kakimoto T., Sandra F., Toh K., et al. RANKL-induced DC-STAMP is essential for osteoclastogenesis. J. Exp. Med. 200 (2004) 941-946
27. Akiyama T., Bouillet P., Miyazaki T., Kadono Y., Chikuda H., Chung U.I., et al. Regulation of osteoclast apoptosis by ubiquitination of proapoptotic BH3-only Bcl-2 family member Bim. EMBO J. 22 (2003) 6653-6664
28. Akiyama T., Miyazaki T., Bouillet P., Nakamura K., Strasser A., and Tanaka S. In vitro and in vivo assays for osteoclast apoptosis. Biol. Proced. Online 7 (2005) 48-59
29. Nakamura M., Udagawa N., Matsuura S., Mogi M., Nakamura H., Horiuchi H., et al. Osteoprotegerin regulates bone formation through a coupling mechanism with bone resorption. Endocrinology 144 (2003) 5441-5449
30. Tsurukai T., Udagawa N., Matsuzaki K., Takahashi N., and Suda T. Roles of macrophage-colony stimulating factor and osteoclast differentiation factor in osteoclastogenesis. J. Bone Miner. Metab. 18 (2000) 177-184
31. Glantschnig H., Fisher J.E., Wesolowski G., Rodan G.A., and Reszka A.A. M-CSF, TNFalpha and RANK ligand promote osteoclast survival by signaling through mTOR/S6 kinase. Cell Death Differ. 10 (2003) 1165-1177
32. Woo K.M., Kim H.M., and Ko J.S. Macrophage colony-stimulating factor promotes the survival of osteoclast precursors by up-regulating Bcl-X(L). Exp. Mol. Med. 34 (2002) 340-346
33. 3 cotransporter NBCn1. Endocrinology 148 (2007) 831-840
34. Okahashi N., Koide M., Jimi E., Suda T., and Nishihara T. Caspases (interleukin-1beta-converting enzyme family proteases) are involved in the regulation of the survival of osteoclasts. Bone 23 (1998) 33-41
35. Tanaka S., Miyazaki T., Fukuda A., Akiyama T., Kadono Y., Wakeyama H., et al. Molecular mechanism of the life and death of the osteoclast. Ann. N. Y. Acad. Sci. 1068 (2006) 180-186
36. Tuttle S.W., Maity A., Oprysko P.R., Kachur A.V., Ayene I.S., Biaglow J.E., et al. Detection of reactive oxygen species via endogenous oxidative pentose phosphate cycle activity in response to oxygen concentration: implications for HIF-1alpha stability under moderate hypoxia. J. Biol. Chem. 282 (2007) 36790-36796
37. Henrotin Y., Kurz B., and Aigner T. Oxygen and reactive oxygen species in cartilage degradation: friends or foes?. Osteoarthr. Cartil. 13 (2005) 643-654
38. Correa G.A., Rumpf R., Mundim T.C., Franco M.M., and Dode M.A. Oxygen tension during in vitro culture of bovine embryos: effect in production and expression of genes related to oxidative stress. Anim. Reprod. Sci. 104 (2007) 132-142
39. Flandin P., Donati Y., Barazzone-Argiroffo C., and Muzzin P. Hyperoxia-mediated oxidative stress increases expression of UCP3 mRNA and protein in skeletal muscle. FEBS Lett. 579 (2005) 3411-3415
40. Chang E., Hornick K., Fritz K.I., Mishra O.P., and Delivoria-Papadopoulos M. Effect of hyperoxia on cortical neuronal nuclear function and programmed cell death mechanisms. Neurochem. Res. 32 (2007) 1142-1149
41. Collin-Osdoby P., Rothe L., Anderson F., Nelson M., Maloney W., and Osdoby P. Receptor activator of NF-kappa B and osteoprotegerin expression by human microvascular endothelial cells, regulation by inflammatory cytokines, and role in human osteoclastogenesis. J. Biol. Chem. 276 (2001) 20659-20672
42. Okada T., Akikusa S., Okuno H., and Kodaka M. Bone marrow metastatic myeloma cells promote osteoclastogenesis through RANKL on endothelial cells. Clin. Exp. Metastasis 20 (2003) 639-646
43. Nakano K., Okada Y., Saito K., Tanikawa R., Sawamukai N., Sasaguri Y., et al. Rheumatoid synovial endothelial cells produce macrophage colony-stimulating factor leading to osteoclastogenesis in rheumatoid arthritis. Rheumatology (Oxford) 46 (2007) 597-603
44. Kizaka-Kondoh S., Inoue M., Harada H., and Hiraoka M. Tumor hypoxia: a target for selective cancer therapy. Cancer Sci. 94 (2003) 1021-1028
45. Goto Y., Noda Y., Mori T., and Nakano M. Increased generation of reactive oxygen species in embryos cultured in vitro. Free Radic. Biol. Med. 15 (1993) 69-75
46. Kurosawa H., Kimura M., Noda T., and Amano Y. Effect of oxygen on in vitro differentiation of mouse embryonic stem cells. J. Biosci. Bioeng. 101 (2006) 26-30
47. Ando W., Hashimoto J., Nampei A., Tsuboi H., Tateishi K., Ono T., et al. Imatinib mesylate inhibits osteoclastogenesis and joint destruction in rats with collagen-induced arthritis (CIA). J. Bone Miner. Metab. 24 (2006) 274-282
48. Sabokbar A., and Athanasou N.S. Generating human osteoclasts from peripheral blood. Methods Mol. Med. 80 (2003) 101-111
49. Kreja L., Liedert A., Schmidt C., Claes L., and Ignatius A. Influence of receptor activator of nuclear (NF)-kappaB ligand (RANKL), macrophage-colony stimulating factor (M-CSF) and fetal calf serum on human osteoclast formation and activity. J. Mol. Histol. 38 (2007) 341-345
50. Udagawa N., Takahashi N., Jimi E., Matsuzaki K., Tsurukai T., Itoh K., et al. Osteoblasts/stromal cells stimulate osteoclast activation through expression of osteoclast differentiation factor/RANKL but not macrophage colony-stimulating factor. Bone 25 (1999) 517-523
51. Muzylak M., Price J.S., and Horton A. Hypoxia induces giant osteoclasts formation and extensive bone resorption in the cat. Calcif. Tissue Int. 79 (2006) 301-309
52. Yasuda H., Shima N., Nakagawa N., Yamaguchi K., Kinosaki M., Goto M., et al. A novel molecular mechanism modulating osteoclast differentiation and function. Bone 25 (1999) 109-113
53. Suda T., Kobayashi K., Jimi E., Udagawa N., and Takahashi N. The molecular basis of osteoclast differentiation and activation. Novartis Found. Symp. 232 (2001) 235-247
54. Katagiri T., and Takahashi N. Regulatory mechanism of osteoblast and osteoclast differentiation. Oral Dis. 8 (2002) 147-159